SSX1, SSX2, and SSX4 are expressed in Hodgkin's lymphoma and head and neck cancer, while SSX1, SSX2, SSX4, and SSX5 are expressed in multiple myeloma. This evidence concerns the gene SSX5 and head and neck cancer.